[{"NetIncomeLoss_1_Q1_USD":-16406000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":26690167.0,"DueFromRelatedPartiesCurrent_0_Q1_USD":561000.0,"CommitmentsAndContingencies_0_Q1_USD":0.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":-2000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q1_pure":0.835,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q1_pure":0.011,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-642000.0,"Depreciation_1_Q1_USD":400000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":787100.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q1_USD":0.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5543000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":3205000.0,"OperatingLeaseExpense_1_Q1_USD":800000.0,"ContractWithCustomerLiability_0_Q1_USD":18777000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4062277.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":99000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":3115000.0,"CommonStockSharesIssued_0_Q1_shares":26694379.0,"Assets_0_Q1_USD":270114000.0,"ShareBasedCompensation_1_Q1_USD":2329000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":7740187.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AssetsCurrent_0_Q1_USD":264501000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":3258000.0,"DepreciationAndAmortization_1_Q1_USD":381000.0,"RevenueFromRelatedParties_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":2225000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":0.0,"ResearchAndDevelopmentExpense_1_Q1_USD":12769000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":26658000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-1450000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-101000.0,"AccountsReceivableNetCurrent_0_Q1_USD":965000.0,"NumberOfReportableSegments_1_Q1_Segment":1.0,"CommonStockValue_0_Q1_USD":3000.0,"Revenues_1_Q1_USD":2000000.0,"DeferredRentCredit_0_Q1_USD":1600000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"OtherSundryLiabilitiesNoncurrent_0_Q1_USD":586000.0,"DerivativeFairValueOfDerivativeLiability_0_Q1_USD":200000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q1_USD":0.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":946000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q1_USD":0.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-16406000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-601000.0,"OtherAssetsNoncurrent_0_Q1_USD":602000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":259865000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":394513000.0,"Liabilities_0_Q1_USD":27683000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-847000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-1035000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-773000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"IncreaseDecreaseInDerivativeLiabilities_1_Q1_USD":92000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":3963608.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":4218000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2329000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_1_Q1_shares":1334099.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-15372000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":3035000.0,"LiabilitiesCurrent_0_Q1_USD":13916000.0,"AccountsPayableCurrent_0_Q1_USD":1284000.0,"NonoperatingIncomeExpense_1_Q1_USD":-94000.0,"CommonStockSharesOutstanding_0_Q1_shares":26694379.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3671000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":99000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":259865000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q1_pure":0.006,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":12396.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":145000.0,"DividendsCommonStock_1_Q1_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":5011000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q1_pure":0.831,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-521000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-152085000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":2000000.0,"OperatingIncomeLoss_1_Q1_USD":-16312000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q1_shares":3158754.0,"InvestmentIncomeInterest_1_Q1_USD":7000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":7087000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":270114000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1306000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2329000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-16861000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":5209.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":9229000.0,"OperatingExpenses_1_Q1_USD":18312000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.61,"ProfitLoss_1_Q1_USD":-16406000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1863000.0,"StockholdersEquity_0_Q1_USD":242431000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":11690000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":642000.0,"DeferredRentCreditNoncurrent_0_Q1_USD":1277000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":3963608.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":1355485.0,"DerivativeLiabilitiesNoncurrent_0_Q1_USD":214000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":2445000.0,"Ticker":"FDMT","CIK":"1650648","name":"4D MOLECULAR THERAPEUTICS INC.","OfficialName":"4D Molecular Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"417797948.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210513"}]